United Therapeutics Corp (UTHR)
234.94
-2.06
(-0.87%)
USD |
NASDAQ |
Apr 25, 10:59
United Therapeutics Total Return Level: 237.00 for April 24, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 24, 2024 | 237.00 |
April 23, 2024 | 234.47 |
April 22, 2024 | 234.06 |
April 19, 2024 | 237.93 |
April 18, 2024 | 236.93 |
April 17, 2024 | 235.31 |
April 16, 2024 | 231.78 |
April 15, 2024 | 235.08 |
April 12, 2024 | 232.59 |
April 11, 2024 | 237.24 |
April 10, 2024 | 237.79 |
April 09, 2024 | 237.04 |
April 08, 2024 | 236.96 |
April 05, 2024 | 233.56 |
April 04, 2024 | 233.93 |
April 03, 2024 | 231.20 |
April 02, 2024 | 228.58 |
April 01, 2024 | 228.26 |
March 28, 2024 | 229.72 |
March 27, 2024 | 243.27 |
March 26, 2024 | 247.86 |
March 25, 2024 | 244.26 |
March 22, 2024 | 237.90 |
March 21, 2024 | 236.93 |
March 20, 2024 | 236.73 |
Date | Value |
---|---|
March 19, 2024 | 239.40 |
March 18, 2024 | 233.97 |
March 15, 2024 | 235.78 |
March 14, 2024 | 238.11 |
March 13, 2024 | 241.27 |
March 12, 2024 | 246.87 |
March 11, 2024 | 249.51 |
March 08, 2024 | 243.05 |
March 07, 2024 | 239.96 |
March 06, 2024 | 236.97 |
March 05, 2024 | 229.81 |
March 04, 2024 | 228.74 |
March 01, 2024 | 231.92 |
February 29, 2024 | 225.64 |
February 28, 2024 | 227.28 |
February 27, 2024 | 226.75 |
February 26, 2024 | 223.58 |
February 23, 2024 | 227.03 |
February 22, 2024 | 217.60 |
February 21, 2024 | 219.18 |
February 20, 2024 | 214.16 |
February 16, 2024 | 214.73 |
February 15, 2024 | 214.54 |
February 14, 2024 | 214.43 |
February 13, 2024 | 213.75 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
74.85
Minimum
Jul 22 2019
280.43
Maximum
Dec 09 2022
175.71
Average
191.34
Median
Oct 25 2021
Total Return Level Benchmarks
Liquidia Corp | 12.55 |
Esperion Therapeutics Inc | 2.13 |
Vertex Pharmaceuticals Inc | 400.76 |
Heron Therapeutics Inc | 2.65 |
Aldeyra Therapeutics Inc | 3.94 |